99% Savings - Buy Just @1 Rs X
Megapose Plus is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Depression.
The right dosage of Megapose Plus depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
These side effects of Megapose Plus are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Megapose Plus is Not Used By Women for pregnant women and Not Used By Women for women who are breastfeeding. Further, the section on Megapose Plus related warnings talks about Megapose Plus's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Megapose Plus contraindications section.
Drug interactions for Megapose Plus have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Megapose Plus, it is important to know that it is not safe while driving, and is not habit-forming.
Megapose Plus is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Megapose Plus safe for pregnant women?
Not Used by Women
Is the use of Megapose Plus safe during breastfeeding?
Not Used by Women
What is the effect of Megapose Plus on the Kidneys?
There can be some harmful effects on your kidneys after taking Megapose Plus. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Megapose Plus on the Liver?
Megapose Plus can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Megapose Plus on the Heart?
Side effects of Megapose Plus on heart are unknown because research on this has not been conducted yet.
Megapose Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Unknown
If you are suffering from any of the following diseases, you should not take Megapose Plus unless your doctor advises you to do so -
Is this Megapose Plus habit forming or addictive?
Yes, Megapose Plus can get addictive. Consume it only after doctor's advise.
Is it safe to drive or operate heavy machinery when consuming?
After taking Megapose Plus, you should not drive or work on any heavy machine, as Megapose Plus can make you drowsy.
Is it safe?
Megapose Plus should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, taking Megapose Plus can treat mental disorders.
Interaction between Food and Megapose Plus
There is no information on the effects of taking Megapose Plus with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Megapose Plus
Drinking alcohol while taking Megapose Plus may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 441
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522